131 related articles for article (PubMed ID: 11753608)
1. Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation.
de Witte T; Pikkemaat F; Hermans J; van Biezen A; Mackinnan S; Cornelissen J; Gratwohl A; Delforge M; Iriondo A; Kuentz M; Harousseau J; Fauser A; Wandt H; Runde V; Niederwieser D; Apperley J;
Leukemia; 2001 Dec; 15(12):1878-84. PubMed ID: 11753608
[TBL] [Abstract][Full Text] [Related]
2. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet JP; Arnold R; Apperley J
Br J Haematol; 2000 Sep; 110(3):620-30. PubMed ID: 10997974
[TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
4. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.
Castro-Malaspina H; Harris RE; Gajewski J; Ramsay N; Collins R; Dharan B; King R; Deeg HJ
Blood; 2002 Mar; 99(6):1943-51. PubMed ID: 11877264
[TBL] [Abstract][Full Text] [Related]
5. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors.
Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA
Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692
[TBL] [Abstract][Full Text] [Related]
6. Stem cell transplantation for patients with myelodysplastic syndrome and secondary leukemias.
De Witte T
Int J Hematol; 2000 Aug; 72(2):151-6. PubMed ID: 11039662
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
8. Stem cell transplantation in myelodysplastic syndromes.
de Witte T
Forum (Genova); 1999; 9(1):75-81. PubMed ID: 10101212
[TBL] [Abstract][Full Text] [Related]
9. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia.
Hows JM; Yin JL; Marsh J; Swirsky D; Jones L; Apperley JF; James DC; Smithers S; Batchelor JR; Goldman JM
Blood; 1986 Dec; 68(6):1322-8. PubMed ID: 3535929
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic cell transplantation from alternative donors in children with myelodysplastic syndrome: is that an alternative?
Kalwak K; Wójcik D; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Pajdosz K; Socha P; Chybicka A
Transplant Proc; 2004 Jun; 36(5):1574-7. PubMed ID: 15251388
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.
Sierra J; Pérez WS; Rozman C; Carreras E; Klein JP; Rizzo JD; Davies SM; Lazarus HM; Bredeson CN; Marks DI; Canals C; Boogaerts MA; Goldman J; Champlin RE; Keating A; Weisdorf DJ; de Witte TM; Horowitz MM
Blood; 2002 Sep; 100(6):1997-2004. PubMed ID: 12200358
[TBL] [Abstract][Full Text] [Related]
12. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
13. Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors.
Bearman SI; Mori M; Beatty PG; Meyer WG; Buckner CD; Petersen FB; Sanders JE; Anasetti C; Martin P; Appelbaum FR
Bone Marrow Transplant; 1994 Jan; 13(1):31-5. PubMed ID: 8019451
[TBL] [Abstract][Full Text] [Related]
14. Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation.
Yam C; Crisalli L; Luger SM; Loren AW; Hexner EO; Frey NV; Mangan JK; Gao A; Stadtmauer EA; Porter DL; Reshef R
Am J Hematol; 2016 Sep; 91(9):883-7. PubMed ID: 27197602
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors.
Blau IW; Schmidt-Hieber M; Basara N; Hopfenmüller W; Bischoff M; Günzelmann S; Kirsten D; Schmetzer B; Roemer E; Kiehl MG; Thiel E; Fauser AA
Clin Transplant; 2007; 21(1):110-6. PubMed ID: 17302599
[TBL] [Abstract][Full Text] [Related]
16. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.
Anderson JE; Anasetti C; Appelbaum FR; Schoch G; Gooley TA; Hansen JA; Buckner CD; Sanders JE; Sullivan KM; Storb R
Br J Haematol; 1996 Apr; 93(1):59-67. PubMed ID: 8611476
[TBL] [Abstract][Full Text] [Related]
17. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
Robin M; Ruggeri A; Labopin M; Niederwieser D; Tabrizi R; Sanz G; Bourhis JH; van Biezen A; Koenecke C; Blaise D; Tischer J; Craddock C; Maillard N; Mohty M; Russel N; Schetelig J; Finke J; Gluckman E; de Witte TM; Rocha V; Kroger N
Biol Blood Marrow Transplant; 2015 Mar; 21(3):489-95. PubMed ID: 25529382
[TBL] [Abstract][Full Text] [Related]
18. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
[TBL] [Abstract][Full Text] [Related]
19. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
Laughlin MJ; Eapen M; Rubinstein P; Wagner JE; Zhang MJ; Champlin RE; Stevens C; Barker JN; Gale RP; Lazarus HM; Marks DI; van Rood JJ; Scaradavou A; Horowitz MM
N Engl J Med; 2004 Nov; 351(22):2265-75. PubMed ID: 15564543
[TBL] [Abstract][Full Text] [Related]
20. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
